Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Global Vaccines Market 2008-2023
2.
Global Biotech Market Analysis and Forecasts, 2008-2023
3.
Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies Markets, Companies and Opportunities
4.
Picture Archiving and Communications Systems (PACS)
5.
Microarray Markets
6.
Medical Nanotechnology Markets
7.
Contract Manufacturing Opportunities in High-Growth Medical Devices (Catheters, Pacemakers, LVADs, Hip and Knee Implants, Air Pathways, Syringes)
8.
Infusion Pump Markets (Large Volume, Ambulatory, Disposable, Syringe, and Specialty Infusion Pumps)
9.
Minimally Invasive Surgical Devices, World Market
10.
Innovative Strategies and Models for R&D Success: The evolving networked pharma company
Best Sellers:
1.
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, March 2008
2.
BioNewsCast Press Release Distribution Service
3.
Peripheral Neuropathy and Neuropathic Pain, 2008
4.
Blood Glucose Testing and Diabetes Management Report
5.
Autoimmune and Inflammation Rheumatoid Arthritis Drug Pipeline Report
6.
The Global Rheumatoid Arthritis Market Forecasts to 2012
7.
Biostatistics course
8.
Worldwide Surgical Sealants, Glues and Wound Closure Market, 2007-2011
9.
Good Manufacturing Practice (GMP) Course
10.
Good Clinical Practice I (GCP) course
Drug Delivery in Cancer - technologies, markets and companies
Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery for cancer. Cancer drug delivery is no longer simply wrapping up cancer drugs in a new formulations for different routes of delivery. The focus is on targeted cancer therapy. The newer approaches to cancer treatment not only supplement the conventional chemotherapy and radiotherapy but also prevent damage to normal tissues and prevent drug resistance.
Innovative cancer therapies are based on current concepts of molecular biology of cancer. These include antiangiogenic agents, immunotherapy, bacterial agents, viral oncolysis, targeting of cyclic-dependent kinases and tyrosine kinase receptors, antisense approaches, gene therapy and combination of various methods. Important methods of immunotherapy in cancer involve use of cytokines, monoclonal antibodies, cancer vaccines and immunogene therapy.
Several innovative methods of drug delivery are used in cancer. These include use of microparticles as carriers of anticancer agents. These may be injected into the arterial circulation and guided to the tumor by magnetic field for targeted drug delivery. Polyethylene glycol (PEG) technology has been used to overcome some of the barriers to anticancer drug delivery. Encapsulating anticancer drugs in liposomes enables targeted drug delivery to tumor tissues and prevents damage to the normal surrounding tissues. Monoclonal antibodies can be used for the delivery of anticancer payloads such as radionucleotides, toxins and chemotherapeutic agents to the tumors.
Antisense oligonucleotides have been in clinical trials for cancer for some time now. RNAi has also been applied in oncology. Small interfering RNAs (siRNAs) can be targeted to tumors and one example is suppression of H-ras gene expression indicating the potential for application in therapy of ovarian cancer. Cancer gene therapy is a sophisticated form of drug delivery for cancer. Various technologies and companies developing them are described. Nucleic acid-based cancer vaccines are also described.
Drug delivery strategies vary according to the type and location of cancer. Role of drug delivery in the management of cancers of the brain, the bladder, the breast, the ovaries and the prostate are used as examples to illustrate different approaches both experimental and clinical. Biodegradable implants of carmustine are already used in the treatment of malignant brain tumors.
The market value of drug delivery technologies and the anticancer drugs are difficult to separate. Cancer market estimates from 2007-2017 are given according to organs involved and the types of cancer as well as according to technologies. Distribution of the into major regions is also described.
Profiles of 189 companies involved in developing innovative cancer therapies and methods of delivery are presented along with their 189 collaborations. The bibliography contains over 580 publications that are cited in the report.The report is supplemented with 52 tables and 7 figures.
Table of contents
Introduction to cancer therapy
Innovative treatments for cancer
Drug delivery systems for cancer
Antisense, RNAi and gene therapy for cancer
Delivery strategies according to cancer type and location
Cancer drug delivery markets
Companies
August 2008. 574 Pages. 53 Tables, 7 Figures, 192 Companies profiled, 213 Alliances listed and 580 References.
Table of Contents
Full Table of Contents (DOC)
Price
PDF Format $3,000.00
Print Format $3,500.00
PDF + Print $4,000.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.